B
BioNexus Gene Lab Corp. (BGLC)
NCM – Real Time Price. Currency in USD
2.07
+0.03 (1.47%)
At close: Jun 26, 2026, 4:00 PM EDT
1.96
-0.11 (-5.31%)
After-hours: Jun 26, 2026, 4:04 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.07
+0.03 (1.47%)
At close: Jun 26, 2026, 4:00 PM EDT
1.96
-0.11 (-5.31%)
After-hours: Jun 26, 2026, 4:04 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $4.0M significantly exceed its total debt $216.4K, ensuring strong financial flexibility
Total current assets $5.2M exceed Total current liabilities $796.5K, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.4), showcasing prudent financial management
Interest coverage ratio (-185.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$148.0K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.52 | 2.71 | 10 | |
| Quick ratio | 5.69 | 1.86 | 10 | |
| Debt to Equity | 0.03 | 0.44 | 9.0 | |
| Debt to Assets | 0.01 | 0.37 | 9.0 | |
| Interest coverage | -185.23 | 72.59 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 11M | 10M | 10M | 7M | 5M |
| Gross Profit | 1M | 1M | 1M | 973K | 691K |
| Operating Income | -470K | -3M | -2M | -3M | -3M |
| Net Income | -356K | -3M | -2M | -3M | -3M |
| EBITDA | -365K | -3M | -2M | -3M | -3M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -95.27 | 47.54 | N/A | -115.4 | 3.3 |
| Y/Y | -98.92 | 12.79 | N/A | 82.04 | 5.0 |
| 3y average | -11.71 | -228.68 | N/A | -138.58 | 1.0 |
| 5y average | -7.2 | -172.94 | N/A | 312.63 | 3.3 |
| Weighted average score | 3.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |